Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Jun;145(6):467-71; discussion 471.
doi: 10.1007/s00701-003-0011-8.

The selective T3 sympathicotomy in patients with essential palmar hyperhidrosis

Affiliations
Clinical Trial

The selective T3 sympathicotomy in patients with essential palmar hyperhidrosis

S-H Yoon et al. Acta Neurochir (Wien). 2003 Jun.

Abstract

Background: Selective T3 thoracoscopic sympathicotomy in patients with essential palmar hyperhidrosis may produce successful results with fewer side effects. We report preliminary results in comparison with those of conventional T2, T3 thoracoscopic sympathicotomy.

Methods: Twenty-four patients underwent a conventional T2, T3 sympathicotomy (group A) from Jan 1997 to Dec 1997 and 30 patients a selective T3 sympathicotomy (group B) from Jan 1998 to Dec 1999. To assess postoperative success and complications all patient charts were reviewed.

Findings: No recurrence was observed in either group. However, the rates of compensatory sweating were significantly (p=0.020) different: 11 patients (45.8%) in group A and 5 patients (16.73%) in group B. Horner's syndrome was observed in only 4 patients of group A.

Interpretation: Selective T3 thoracoscopic sympathicotomy results in a decrease in the rate of disturbing side effects compared to conventional T2, T3 thoracoscopic sympathicotomy without recurrence of symptoms. We suggest that selective T3 thoracoscopic sympathicotomy is the treatment of choice in essential palmar hyperhidrosis.

PubMed Disclaimer

LinkOut - more resources